Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma

被引:12
|
作者
Ortiz-Cuaran, Sandra [1 ]
Cox, David [2 ]
Villar, Stephanie [1 ]
Friesen, Marlin D. [3 ]
Durand, Geoffroy [1 ]
Chabrier, Amelie [1 ]
Khuhaprema, Thiravud [4 ]
Sangrajrang, Suleeporn [4 ]
Ognjanovic, Simona [5 ,6 ]
Groopman, John D. [3 ]
Hainaut, Pierre [1 ]
Le Calvez-Kelm, Florence [1 ]
机构
[1] Int Agcy Res Canc, F-69372 Lyon, France
[2] Canc Res Ctr Lyon, INSERM, U1052, Lyon, France
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Natl Canc Inst, Bangkok, Thailand
[5] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[6] Int Prevent Res Inst, Lyon, France
来源
GENES CHROMOSOMES & CANCER | 2013年 / 52卷 / 10期
关键词
P53; CANCER; DNA; VARIANTS; PATHWAY; RISK;
D O I
10.1002/gcc.22086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over 100 single nucleotide polymorphisms (SNP) are validated in the TP53 tumor suppressor gene. They define haplotypes, which may differ in their activities. Therefore, mutation in cancer may occur at different rates depending upon haplotypes. However, these associations may be masked by differences in mutations types and causes of mutagenesis. We have analyzed the associations between 19 SNPs spanning the TP53 locus and a single specific aflatoxin-induced TP53 mutation (R249S) in 85 in hepatocellular carcinoma cases and 132 controls from Thailand. An association with R249S mutation (P=0.007) was observed for a combination of two SNPs (rs17882227 and rs8064946) in a linkage disequilibrium block extending from upstream of exon 1 to the first half of intron 1. This domain contains two coding sequences overlapping with TP53 (WRAP53 and Hp53int1) suggesting that sequences in TP53 intron 1 encode transcripts that may modulate R249S mutation rate in HCC. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:912 / 919
页数:8
相关论文
共 50 条
  • [21] Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER, 2012, 118 (05) : 1387 - 1396
  • [22] Association of TP53 Polymorphisms on the Risk of Wilms Tumor
    Andrade, R. C.
    Cardoso, L. C. A.
    Ferman, S. E.
    Faria, P. S.
    Seuanez, H. N.
    Achatz, M. I.
    Vargas, F. R.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (03) : 436 - 441
  • [23] TP53 polymorphisms and association with endometriosis in Brazilian population
    Carvalho, Cristina Valletta
    Camargo-Kosugi, Cintia Meirelles
    Kosugi, Eduardo Macoto
    D'Amora, Paulo
    Rojas, Jessica Vidal
    Schor, Eduardo
    Cotrim Guerreiro da Silva, Ismael Dale
    FASEB JOURNAL, 2010, 24
  • [24] Depicting the role of TP53 in hepatocellular carcinoma progression
    Villanueva, Augusto
    Hoshida, Yujin
    JOURNAL OF HEPATOLOGY, 2011, 55 (03) : 724 - 725
  • [25] Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer
    Mohamadkhani, Ashraf
    Naderi, Elnaz
    Sharafkhah, Maryam
    Fazli, Hamid Reza
    Moradzadeh, Malihe
    Pourshams, Akram
    JOURNAL OF ONCOLOGY, 2013, 2013
  • [26] Mutational signature in urothelial carcinoma with TP53 mutation
    Liu, H. H.
    Liang, X. Y.
    Chen, L. B.
    Zhang, Y.
    Wang, H. N.
    Lou, F.
    Cao, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1321 - S1321
  • [27] A polymorphism in intron 2 of the TP53 gene
    DiCioccio, RA
    Piver, MS
    CLINICAL GENETICS, 1996, 50 (02) : 108 - 109
  • [28] TP53 mutation, mitochondria and cancer
    Kamp, William M.
    Wang, Ping-yuan
    Hwang, Paul M.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2016, 38 : 16 - 22
  • [29] TP53 Mutation in Waldenstrom Macroglobulinemia
    Poulain, Stephanie
    Roumier, Christophe
    Bertrand, Elisabeth
    Renneville, Aline
    Tricot, Sabine
    Venet, Aurelie Caillault
    Geffroy, Sandrine
    Nudel, Morgan
    Herbaux, Charles
    Guidez, Stephanie
    Preudhomme, Claude
    Leleu, Xavier
    BLOOD, 2016, 128 (22)
  • [30] TP53 mutation in colorectal cancer
    Iacopetta, B
    HUMAN MUTATION, 2003, 21 (03) : 271 - 276